Artichoke Leaf Extract
Also sold as: Artichoke Supplements
Best-in-class: Artichoke Extract
A choleretic bitter — it increases bile flow. One of the better-evidenced botanicals for functional dyspepsia, and a genuinely underrated one.
Artichoke Leaf Extract quick facts
| Suggested dose | 320–640 mg standardized extract before meals. |
| How often | Per meal, or daily during a course |
| Who it's for | Bloating and fullness after fatty meals; sluggish digestion; a mild lipid adjunct. |
Good trial evidence for functional dyspepsia and for lipid improvement, plus liver-enzyme reduction in fatty liver studies. The bile-flow mechanism makes it genuinely useful in a detoxification context, where elimination is the step most people skip. Contraindicated in bile duct obstruction. It is in the ragweed family, so cross-allergy is possible.
How Artichoke Leaf Extract actually works
Cynarin and related caffeoylquinic acids are choleretic — they increase bile production and flow, which improves fat digestion and provides the physical exit route for compounds the liver has conjugated. Artichoke also inhibits HMG-CoA reductase modestly, which is the basis of its lipid effect.
Where to get Artichoke Leaf Extract
Find Artichoke Leaf Extract on iHerb →What it is, why it recurs, and where this fits — free to read.
The evidence for Artichoke Leaf Extract
Graded by what exists behind each claim.
✅ Clinically validated
- RCTs show reduced symptoms in functional dyspepsia — bloating, early fullness and nausea — with reasonably consistent results.
- A randomized trial in IBS showed reduced symptom severity and a shift away from alternating-type symptoms.
- Meta-analyses show modest reductions in total and LDL cholesterol.
📊 Correlative data
- Long traditional use as a digestive bitter across Mediterranean cuisine and medicine.
🧪 Theoretical / extrapolated benefits
- Bile flow is the proposed mechanism for both the digestive and the lipid effects — more bile means better fat handling and more cholesterol excreted rather than recycled.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Artichoke Leaf Extract actually does
One plant, two mechanisms, two different molecules, and almost every page written about it blurs them into one sentence about bile. They should be kept apart, because they predict different doses, different read-outs and different timescales.
Mechanism one is bitterness, and the receptor family has a name. The bitter principle of artichoke leaf is cynaropicrin, a sesquiterpene lactone. Bitter compounds act on TAS2R receptors, which are expressed on the tongue and also on enteroendocrine cells down the gut, and the classical digestive-bitter reflex runs from the oral receptor through vagal efferents to gallbladder contraction and gastric secretion. Labeled as reasoning rather than trial evidence: if any part of the digestive benefit depends on that reflex, then a capsule swallowed whole has bypassed the receptors the mechanism starts at, and no trial has ever separated the tasted dose from the swallowed one.
Mechanism two is choleresis, and it was measured with a tube. Bile secretion was recorded directly after 1.92 g of artichoke extract in 20 subjects: a 127.3% increase at 30 minutes, 151.5% at 60 minutes, and 94.3% an hour after that Kirchhoff 1994. More bile means more emulsification of a fatty meal, and it also means more cholesterol leaving the body as bile rather than being recycled.
Mechanism three is hepatic, and the active molecule is not the one on the label. Artichoke extracts inhibit cholesterol biosynthesis in HepG2 cells — almost 60% inhibition at 0.2 mg/mL — and the compound responsible was identified as luteolin. Critically, pretreating the extract with beta-glucosidase reinforced the effect Gebhardt 2002. Luteolin travels in the plant as luteolin-7-O-glucoside; the sugar has to come off before the aglycone can act. In a person that cleavage is done by intestinal lactase-phlorizin hydrolase and by colonic bacteria, which makes the size of the lipid effect partly a property of the eater rather than of the capsule.
So the honest summary of the mechanism is that the plant has three of them, sold as one. A bitter reflex that a capsule may defeat, a choleretic effect demonstrated by intraduodenal infusion, and a hepatic enzyme effect belonging to a flavone nobody standardizes for.
Cell, rodent, human — and where it stops
Cells. HepG2 hepatocytes exposed to artichoke extract at 0.01–0.2 mg/mL, with cholesterol biosynthesis inhibited by nearly 60% at the top concentration and luteolin identified as the active Gebhardt 2002. That is a clean concentration-response in a human liver cell line.
The bile experiment, and its route. Twenty subjects, randomized placebo-controlled double-blind crossover, a single 1.92 g dose delivered intraduodenally Kirchhoff 1994. Read that again: the extract was placed past the stomach through a tube. Nobody swallows anything that way, the dose is three times the top of this site's card, and the entire bile-flow claim that this product is sold on rests on that single experiment in twenty people.
The dyspepsia trial is the largest thing here, and its effect size is small. Two hundred and forty-four patients analyzed — 129 on extract, 115 on placebo — took 2 × 320 mg for six weeks. Overall symptom improvement was 8.3 ± 4.6 against 6.7 ± 4.8 on placebo (P < 0.01), with quality of life on the Nepean index at −41.1 ± 47.6 against −24.8 ± 35.6 (P < 0.01) Holtmann 2003. The gap is real and it is about a third of a standard deviation. Placebo did most of the work in both arms.
The irritable bowel data are open-label, and that has to be said before the number is. Two hundred and eight adults in a subset analysis of an open postal dose-ranging study reported a 26.4% fall in irritable bowel incidence (P < 0.001), a 41% fall in total dyspepsia symptom score and a 20% rise in quality of life over two months Bundy 2004. No placebo arm, no blinding, self-completed by post. Those percentages are much larger than the controlled trial's and the design is much weaker; both facts are consequences of the same thing.
The lipid data are the firmest, and they are modest. Seventy-five adults with mild to moderately raised cholesterol took 1280 mg of standardized extract daily for 12 weeks: total cholesterol fell 4.2%, from 7.16 (SD 0.62) to 6.86 (SD 0.68) mmol/L, while the control group rose 1.9%, difference P = 0.025 Bundy 2008. Pooling nine randomized trials in 702 people gives total cholesterol down 17.6 mg/dL (95% CI −22.0 to −13.3, P < 0.001), LDL down 14.9 mg/dL (95% CI −20.4 to −9.5, P = 0.011) and triglycerides down 9.2 mg/dL (95% CI −16.2 to −2.1, P = 0.011) Sahebkar 2018.
The obstacle here is the dose, and this site's card is set for one claim while readers use it for the other. The card advises 320–640 mg, which is the dyspepsia dose Holtmann 2003. The lipid result belongs to 1280 mg Bundy 2008 — double it — and the bile result to 1920 mg through a tube Kirchhoff 1994. Somebody taking one 320 mg capsule for their cholesterol is running a quarter of the studied dose and should predict accordingly.
Artichoke Leaf Extract — which form, and does it matter
Standardized to cynarin is standardizing to the wrong molecule. Cynarin is 1,3-dicaffeoylquinic acid, and a substantial part of what is measured as cynarin in an extract forms during extraction from chlorogenic acid rather than existing in the fresh leaf. It is not the compound with the hepatic mechanism — that is luteolin Gebhardt 2002 — and it is not the bitter principle, which is cynaropicrin. A cynarin percentage is a manufacturing consistency check being sold as a potency claim.
The glucoside is the reason two people can take the same capsule and get different exposures. Luteolin arrives glycosylated, and enzymatic removal of the sugar increased the inhibition of cholesterol synthesis in the cell work Gebhardt 2002. Deglycosylation in a person depends on brush-border enzyme activity and on colonic bacteria, so the delivered aglycone dose varies between people in a way the label cannot capture. Nobody sells a deglycosylated extract, and on this evidence somebody should.
Leaf, not the vegetable. Every trial cited here used a leaf extract Holtmann 2003 Bundy 2008 Kirchhoff 1994. The edible bud is a different tissue with a different composition, and eating artichokes is not a small dose of this product.
Capsule or bitter liquid is a real formulation question, not a preference. If the digestive half runs partly through bitter receptors, then a tincture held in the mouth before a meal and a coated capsule swallowed with water are two different interventions. Every controlled trial used a swallowed preparation Holtmann 2003 Bundy 2008, so the tasted version is the one with no evidence — which is the opposite of what the traditional-bitters framing implies.
What would have to be true, and how you would know it was not
1. The lipid panel is the falsifiable half, and 12 weeks is the window. At 1280 mg/day, predict total cholesterol down by a few percent and ldl down by roughly 10–15 mg/dL — that is what the controlled trial Bundy 2008 and the nine-trial pooled estimate Sahebkar 2018 actually support. Check apob alongside it, because apob counts the particles and a small fall in cholesterol mass with no change in particle number is a smaller result than it looks. Retest at 12 weeks, not at 4.
2. The prediction that cuts against the product, twice over. Predict no measurable lipid change at the card's 320–640 mg dose, because that is half to a quarter of the studied one Bundy 2008. And predict nothing at all in someone whose LDL is already at target — a 4.2% fall from 7.16 mmol/L is a different arithmetic from a 4.2% fall from a normal value, and the trial was run in people with raised cholesterol.
3. The digestive read-out is post-meal fullness, and the honest prediction is a small win. Six weeks at 640 mg produced a symptom score of 8.3 against 6.7 on placebo Holtmann 2003. Predict a noticeable-but-modest change in early fullness and upper-abdominal discomfort after fatty meals by week six, and predict that a large obvious effect is more likely to be the placebo arm's 6.7 than the extract's extra 1.6.
4. Predict the liver panel does not move, and know what it would mean if it did. A choleretic increases bile output; it does not damage hepatocytes or obstruct ducts, so predict ggt, ALT and bilirubin on a cmp are unchanged at 12 weeks. A rise in ggt or bilirubin on this is not a supplement side effect to titrate around — it is a reason to look for a stone, which is also the population that should not be taking a choleretic in the first place.
What nobody has tested yet
Nobody has measured bile output after a swallowed capsule. The single choleresis study infused 1.92 g into the duodenum through a tube Kirchhoff 1994. Whether an oral 640 mg capsule raises bile flow at all — after gastric emptying, after dilution, at a third of the dose — has never been measured, and it is the claim on the front of every bottle.
Nobody has compared a luteolin-standardized extract with a cynarin-standardized one. The cell work points at luteolin and at its glucoside Gebhardt 2002; the industry standardizes to cynarin. A head-to-head with a lipid endpoint would either vindicate the existing assay or make every label on the shelf obsolete, which may be why it has not been run.
Nobody has asked whether deglycosylation capacity predicts who responds. If the aglycone is the active and the sugar has to come off first Gebhardt 2002, then responders and non-responders should be separable in advance by brush-border enzyme activity or by stool sequencing. No lipid trial has stratified anyone that way, so the pooled 14.9 mg/dL Sahebkar 2018 may be averaging two populations with quite different results.
And nobody has run tasted against swallowed. A tincture held in the mouth versus the same dose in a capsule, with gastric accommodation or post-meal fullness as the endpoint, would test the bitter-reflex mechanism directly. It is a cheap crossover in twenty people and it would settle a two-hundred-year-old claim.
Artichoke Leaf Extract — its own safety story, not its category's
The contraindication follows from the mechanism, and it is specific. This increases bile flow Kirchhoff 1994. Driving flow through a duct occupied by a stone is how biliary colic happens, so gallstones and biliary obstruction are not a generic caution here — they are the exact situation the mechanism makes worse, and they are common and often silent in the middle-aged population that buys digestive bitters.
The allergy is to a chemical class, not to a plant name. Artichoke is a Compositae, and the sensitizers in that family are sesquiterpene lactones — the same chemical class as the cynaropicrin that makes the leaf bitter. Anyone with contact or respiratory sensitivity to ragweed, chrysanthemum, marigold or feverfew is being exposed to a related molecule, and that is a more useful warning than a list of flowers.
It lowers cholesterol, so it stacks with drugs that do the same. A pooled LDL reduction of 14.9 mg/dL Sahebkar 2018 is small next to a statin and is not zero, and it is additive rather than parallel. If you start this on a statin or on ezetimibe, the correct response is to retest the lipid panel rather than to assume a botanical is too weak to change a prescribing decision.
The honest limit is duration. Six weeks in 244 people Holtmann 2003 and 12 weeks in 75 Bundy 2008 are the longest controlled exposures. There is no multi-year data on daily use of a choleretic, and the population most likely to take it forever — people with recurring post-meal fullness — is also the population in which an undiagnosed biliary problem is most likely to be the reason.
Sources read for this page
- Kirchhoff R. Increase in choleresis by means of artichoke extract.. Phytomedicine 1994 · PMID 23195882
- Gebhardt R. Inhibition of cholesterol biosynthesis in HepG2 cells by artichoke extracts is reinforced by glucosidase pretreatment. Phytother Res 2002 · PMID 12112295
- Holtmann G. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial.. Aliment Pharmacol Ther 2003 · PMID 14653829
- Bundy R. Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: a subset analysis.. J Altern Complement Med 2004 · PMID 15353023
- Bundy R. Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial.. Phytomedicine 2008 · PMID 18424099
- Sahebkar A. Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis. Crit Rev Food Sci Nutr 2018 · PMID 28609140
How you would know if it worked
Bile flow is the proposed mechanism for both halves of this plant — the digestive one and the lipid one — because more bile means more cholesterol excreted rather than recycled. The lipid half is the half a blood draw can settle, and meta-analyses report modest reductions in total and LDL cholesterol, so modest is what you should be looking for.
- Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) Retest: Every 3–6 months on androgens; annually otherwise.
- ApoB (Apolipoprotein B) Retest: Every 3–6 months on androgens or after any intervention; annually otherwise.
The cheapest panel carrying Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) and at least one other of these is Metabolic Health & Prediabetes, at $90 — the panel is named for a different question, and the marker is the same marker. That is the whole cost of finding out.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
Artichoke Leaf Extract — safety & side effects
- Gas, cramping and loose stools — it is choleretic, meaning it increases bile flow.
- Avoid with bile duct obstruction or gallstones — increasing bile flow against an obstruction is the wrong direction.
- Allergy in people sensitive to ragweed and daisies. Lowers cholesterol modestly.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Artichoke Leaf Extract in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Artichoke Leaf Extract
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | Anemia is the commonest sign of a gut absorbing badly |
| Ferritin | Iron is the first thing malabsorption takes |
| Vitamin B12 | The second thing, and the one with permanent consequences |
| hs-CRP (High-Sensitivity C-Reactive Protein) | Separates inflammatory bowel disease from IBS |
The Gut Health & Absorption panel covers these in one order — 11 markers, $208.80 with the discount applied.
Check results you already have → · All 103 markers A–Z
Artichoke Leaf Extract — frequently asked questions
What is Artichoke Leaf Extract?
A choleretic bitter — it increases bile flow. One of the better-evidenced botanicals for functional dyspepsia, and a genuinely underrated one.
What is the suggested dose of Artichoke Leaf Extract?
320–640 mg standardized extract before meals. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Artichoke Leaf Extract dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Artichoke Leaf Extract?
Coach Cam sources Artichoke Leaf Extract from vetted, top-rated brands on iHerb — use the buy link on this page.
Artichoke Leaf Extract inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Artichoke Leaf Extract is used for
Artichoke Leaf Extract appears under 3 goals in the goal router.
Related Gut & Digestion supplements
Where this goes next
Artichoke Leaf Extract is the hepatocyte arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.